-
Insights from SCOPE | Machine-readable protocols can do more than streamline documentation. They create the structured foundation AI needs to improve study startup, feasibility, and trial execution. Explore why the future of clinical operations may begin with rethinking the protocol itself.
Jul 2, 2026
-
Insights from SCOPE | Study startup decisions have traditionally relied on experience and historical data. Discover how operational intelligence, workflow visibility, and AI are helping teams make faster, better-informed decisions before startup risks become execution problems.
Jun 30, 2026
-
Insights from SCOPE | Strong sponsor-site partnerships don't begin with startup and end at closeout. Discover how long-term collaboration, operational transparency, and shared learning can reduce friction, improve trial execution, and create lasting value across every study in a development portfolio.
Jun 25, 2026
-
Insights from SCOPE | Clinical trial startup continues to slow despite growing investment in technology and automation. Explore how protocol complexity, fragmented processes, incomplete operational visibility, and internal misalignment create delays—and why removing friction may matter more than adding new tools.
Jun 23, 2026
-
Insights from SCOPE | Many enrollment challenges begin long before patient outreach starts. Explore why protocol design, site feasibility, community engagement, and patient support function as a connected recruitment system—and why stronger systems often matter more than bigger campaigns.
Jun 18, 2026
-
Insights from SCOPE | Many patients who qualify for a clinical trial never enroll—not because they lack interest, but because they lack confidence. Explore why patient readiness, trust, education, and practical support may be just as important as eligibility in driving enrollment success.
Jun 16, 2026
-
Insights from SCOPE | Embedding clinical research into routine care can expand access, reduce patient burden, and improve scalability without compromising oversight. Explore how integrated care pathways, hub-and-spoke models, and pragmatic protocol design are reshaping the next phase of trial delivery.
Jun 11, 2026
-
Insights from SCOPE | Sponsors and sites often see digital adoption differently. Explore how misaligned assumptions, workflow gaps, and integration challenges shape real-world site technology use — and why early collaboration is essential to making digital tools reduce burden instead of increasing it.
Jun 9, 2026
-
Insights from SCOPE | Decentralization only delivers real value when it’s designed as an operating model, not a collection of tools. Explore how flexible, community-integrated trial delivery models are expanding access, reducing burden, and reshaping how research is embedded into routine care.
Jun 4, 2026
-
Insights from SCOPE | Clinical research is entering a transitional phase of AI adoption — beyond pilots, but not yet autonomous. Explore how modular scaling, human-in-the-loop design, and disciplined governance are shaping the industry’s middle phase and defining what sustainable AI integration truly looks like.
Jun 2, 2026
-
Insights from SCOPE | AI in clinical trials must do more than perform accurately. It must be explainable, traceable, and defensible under regulatory scrutiny. Explore what separates experimental AI from regulatory-grade systems built for trust, transparency, and sustainable enterprise deployment.
May 28, 2026
-
Insights from SCOPE | AI will not transform clinical trials by automating isolated tasks. Real impact comes when workflows are redesigned around structured data, coordinated execution, and built-in governance. Explore how organizations are moving beyond incremental efficiency toward intelligent clinical operating models.
May 26, 2026
-
Insights from SCOPE | Following up on SCOPE X, one message stands out: AI impact depends less on model sophistication and more on data foundations, workflow redesign, governance, and measurable business value. Explore the signals shaping how clinical research is embedding AI responsibly and at scale.
May 21, 2026
-
Insights from SCOPE | AI in clinical development is shifting from experimentation to measurable business impact. Explore where artificial intelligence is truly driving value across startup, enrollment, governance, and portfolio strategy — and why strong data foundations and oversight determine long-term success.
May 19, 2026
-
Insights from SCOPE | Clinical leaders are moving beyond AI experimentation and into real operational decisions. Explore five strategic questions that will shape how artificial intelligence transforms clinical trial design, execution, governance, and human oversight in 2026 and beyond.
May 14, 2026
-
Insights from SCOPE | AI in clinical research has moved beyond pilots. From study startup to risk monitoring and recruitment coordination, real-world use cases are already delivering measurable impact. Explore five practical applications transforming clinical operations before the conversation continues at SCOPE X.
May 12, 2026
-
Insights from SCOPE | Challenges around rare disease recruitment aren't always about patient volume. Precision matters. When eligibility depends on specific mutations or biomarkers, traditional funnels fall short. Learn how mutation-aware outreach and structured data can connect the right patients to the right trials faster.
May 7, 2026
-
Insights from SCOPE | Most recruitment challenges don’t begin when enrollment stalls. They start months earlier in protocol design and feasibility assumptions. Learn how bringing real-world data upstream can prevent downstream delays, reduce screen failures, and improve enrollment predictability before the first patient is contacted.
May 5, 2026
-
Insights from SCOPE | The FDA’s move to pilot real-time clinical trial data access is a signal of where the industry is heading, not a sudden change in direction. For years, clinical operations teams have been working toward faster, more connected ways of generating and acting on data. What’s changing now is who participates in that environment.
Instead of reviewing submissions after the fact, regulators are beginning to explore what it looks like to engage with trial data as it evolves. That shift, from periodic review to continuous visibility, creates an opportunity to rethink how trials are designed, executed, and monitored.
For clinical teams, this is less about disruption and more about alignment with work already in progress.
Apr 30, 2026
-
Insights from SCOPE | CRFs, edit checks, statistical analysis plans, protocol abstractions. Study startup artifacts are highly structured, deeply interdependent, and almost always time-compressed.
They are also repeatable.
Within a therapeutic area, much of the logic behind these artifacts is reused across studies. Visit schedules follow familiar patterns. Edit-check rules draw from established standards. Statistical plan sections mirror protocol language with predictable mappings. Despite this, teams frequently rebuild them manually, adapting prior versions line by line under tight timelines.
That manual rebuild cycle adds weeks to startup and introduces inconsistency that surfaces later during data cleaning or regulatory review.
AI is beginning to change this phase of development, but the real opportunity is not just faster drafting. It is controlled acceleration.
Apr 28, 2026